German doctors face investigation in drugs scandalBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7339.693 (Published 23 March 2002) Cite this as: BMJ 2002;324:693
- Annette Tuffs
Some 3500 doctors in several German towns are currently being investigated for alleged undue financial advantages and corruption after aggressive marketing by a drugs company.
The district attorney's office in Munich, which is carrying out the investigation, said that suspicions were raised over excessive marketing activities by SmithKline Beecham, the company which merged in 2000 with GlaxoWellcome to form GlaxoSmithKline. From 1997 to 1999 SmithKline Beecham invited hospital doctors and their spouses to conferences in Germany and abroad.
An additional 5800 payments of up to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial